An ANDA, or Abbreviated New Drug Application, is the FDA's pathway for approving generic drugs. It allows manufacturers to prove their product is equivalent to a brand-name drug without repeating costly clinical trials, saving billions annually and making medications affordable for millions.
Learn more...